Janssen Submits Marketing Authorisation Application to European Medicines Agency for a Fixed-Dose Combination Tablet of HIV-1 Medicine Darunavir with Cobicistat
- EMEA Innovative Medicine
- Janssen Submits Marketing Application for HIV-1 Medicine Darunavir
Janssen Submits Marketing Application for HIV-1 Medicine Darunavir
- X (Twitter)
Copy link